Polypipe Group /£GEN

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Polypipe Group

Polypipe Group, trading under the ticker GEN, is a manufacturer specializing in water management and plastic piping systems. Established in 1980, the company operates primarily within the construction and infrastructure sectors. Polypipe offers a wide range of products aimed at addressing critical challenges in water, climate, and ventilation management, contributing to the development of green building solutions.

Ticker

£GEN

Primary listing

LSE

Employees

3,200

Polypipe Group Metrics

BasicAdvanced
£900M
18.60
£0.19
1.40
£0.13
3.50%

What the Analysts think about Polypipe Group

Analyst ratings (Buy, Hold, Sell) for Polypipe Group stock.

Bulls say / Bears say

Genuit reported 9.3% year-on-year revenue growth to £297.8 million in H1 2025, with 6.1% like-for-like growth and underlying profit before tax up 3.2% to £38.8 million, demonstrating strong market execution (LSE RNS)
The £55.6 million acquisition of Monodraught boosts Genuit’s Climate Management Solutions division with a top commercial ventilation company that achieved a 13% organic revenue CAGR (2021–2024) and holds a sizable ~£19 million order book for 2025 (Alliance News)
Pro-forma net debt leverage improved to 1.0x EBITDA in H1 2025 from 1.1x a year ago, strengthening balance sheet flexibility for strategic investments and bolt-on acquisitions (MarketScreener)
Underlying operating margin narrowed by 100bps to 15.0% in H1 2025, pressed by higher National Insurance, minimum wage costs, and a £0.9 million slow-moving inventory provision (LSE RNS)
Underlying operating cash conversion dropped sharply to 65.1% in H1 2025 from 99.5% in H1 2024, highlighting potential working capital and cash flow challenges (MarketScreener)
Genuit shares declined over 8% on August 12 after cautioning on flat market volumes and continued cost pressures, emphasizing investor concern over the sustainability of volume growth (Alliance News)
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2025.

Polypipe Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Polypipe Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £GEN

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs